UNVERIFIEDSingle SourceSTAT+: Government watchdog urges FDA to finalize guidance for advisory committee conflicts of interestStat News|4/1/2026
UNVERIFIEDSingle SourceSTAT+: Biogen to acquire immunology biotech Apellis for $5.6 billionStat News|3/31/2026
UNVERIFIEDSingle SourceSTAT+: Up and down the ladder: The latest comings and goingsStat News|3/27/2026
UNVERIFIEDSingle SourceSTAT+: Allogene’s off-the-shelf CAR-T is nearing an early but pivotal study readoutStat News|3/26/2026
UNVERIFIEDSingle SourceSTAT+: Drug company penalties for paying kickbacks to doctors failed to dent bottom lines, analysis findsStat News|3/24/2026
UNVERIFIEDSingle SourceSTAT+: FDA slams Soon-Shiong and ImmunityBio for making ‘false and misleading’ claims about a drugStat News|3/24/2026
UNVERIFIEDSingle SourceSTAT+: The potential loophole in Trump’s plan to get other countries to pay more for drugsStat News|3/24/2026
UNVERIFIEDSingle SourceSTAT+: This bill could make CVS choose between its stores and its pharmacy benefit managerStat News|3/23/2026
UNVERIFIEDSingle SourceSTAT+: U.K. to take another look at cost-effectiveness of Alzheimer’s drugsStat News|3/20/2026
UNVERIFIEDSingle SourceSTAT+: Novartis picks up experimental breast cancer therapy for $2BStat News|3/20/2026
UNVERIFIEDSingle SourceDrug development is booming in China. Should the U.S. view it as a threat or an opportunity?Stat News|3/19/2026
UNVERIFIEDSingle SourceSTAT+: Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trialStat News|3/19/2026
UNVERIFIEDSingle SourceSTAT+: Six drugmakers, six months: Charting the FDA’s course in the post-Prasad eraStat News|3/19/2026
UNVERIFIEDSingle SourceSTAT+: J&J wins approval for first-of-its-kind psoriasis pillStat News|3/18/2026
UNVERIFIEDSingle SourceHow STAT would cover ‘The Fugitive’ if its pharma scandal were realStat News|3/13/2026
UNVERIFIEDSingle SourceSTAT+: A top biotech VC quietly helped Epstein’s ‘great friend’ make a comebackStat News|3/11/2026
UNVERIFIEDSingle SourceSTAT+: Large drugmakers are developing fewer antibiotics, analysis findsStat News|3/10/2026
UNVERIFIEDSingle SourceSTAT+: Vertex says its drug successfully reduced marker of kidney disease in late-stage trialStat News|3/9/2026
UNVERIFIEDSingle SourceSTAT+: Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy salesStat News|3/9/2026
UNVERIFIEDSingle SourceSTAT+: Novo Nordisk’s Wegovy and Ozempic shots could be made for as little as $3 a month, analysis findsStat News|3/6/2026
UNVERIFIEDSingle SourceSTAT+: Up and down the ladder: The latest comings and goingsStat News|3/6/2026
UNVERIFIEDSingle SourceSTAT+: Servier to acquire Day One, maker of pediatric cancer drug, for $2.5BStat News|3/6/2026
UNVERIFIEDSingle SourceWe Lost the Lyme Vaccine. Under Rand Paul's New Vaccine Liability Bill, We'll Lose More.Reason Magazine|3/5/2026
UNVERIFIEDSingle SourceSTAT+: The extremism of the FDA’s Marks and Prasad has come with costsStat News|3/5/2026
UNVERIFIEDSingle SourceSTAT+: FDA is ‘not convinced’ UniQure’s Huntington’s therapy has benefit, senior official saysStat News|3/3/2026
UNVERIFIEDSingle SourceSTAT+: UniQure plans to seek approval for Huntington’s therapy still blocked by FDAStat News|3/2/2026
UNVERIFIEDSingle SourceSTAT+: Justice Department backs AbbVie in its bid to overturn a Colorado law guiding a drug discount programStat News|2/26/2026
UNVERIFIEDSingle SourceSTAT+: Novo Nordisk strikes deal with U.S. startup to develop oral obesity, diabetes drugsStat News|2/25/2026
UNVERIFIEDSingle SourceSTAT+: Drugmakers lay out their legal arguments against Trump’s drug pricing experimentsStat News|2/24/2026
UNVERIFIEDSingle SourceSTAT+: New treatment approach could give IBD patients hope, and be a bonanza for drugmakersStat News|2/24/2026
UNVERIFIEDSingle SourceSTAT+: In first speech to her FDA staff, Høeg says she’ll scrutinize RSV shots and SSRIs in pregnancyStat News|2/19/2026
UNVERIFIEDSingle SourceThe FDA Talks Over-the-Counter Freedom. Big Pharma Profits From Keeping It Restricted.Reason Magazine|2/19/2026
UNVERIFIEDSingle SourceSTAT+: New FDA guidance for antibiotic use in food-producing animals prompts criticism over antibiotic resistanceStat News|2/18/2026
UNVERIFIEDSingle SourceSTAT+: At drugmakers’ forum, Oz gets a friendly embrace, while Makary faces tough questionsStat News|2/17/2026
UNVERIFIEDSingle SourceOpinion: When IV opioids are in short supply at the hospital, who gets pain relief?Stat News|2/17/2026
UNVERIFIEDSingle SourceSTAT+: Up and down the ladder: The latest comings and goingsStat News|2/13/2026
UNVERIFIEDSingle SourceOpinion: My granddaughter has a rare disease. But clinical trials often exclude patients like herStat News|2/11/2026
UNVERIFIEDSingle SourceSTAT+: HHS asks Justice Department to probe Hims & Hers over its cheaper compounded version of WegovyStat News|2/7/2026
UNVERIFIEDSingle SourceSTAT+: White House looks for more drug pricing deals to add to TrumpRxStat News|2/6/2026
UNVERIFIEDSingle SourceSTAT+: Roivant immune drug significantly outperformed placebo in treating rare skin diseaseStat News|2/6/2026
UNVERIFIEDSingle SourceStatins don’t cause most of the side effects on package warnings, study findsStat News|2/5/2026
UNVERIFIEDSingle SourceChallenges for a crucial sickle cell treatment and the latest outlook for GLP-1sStat News|2/5/2026
UNVERIFIEDSingle SourceA sneak peek of pharma’s Super Bowl ads: GLP-1s, tight ends, and moreStat News|2/5/2026
UNVERIFIEDSingle SourceNew PBM law could open door to direct sales between employers, drugmakersStat News|2/4/2026
UNVERIFIEDSingle SourceSTAT+: Trump administration officials blocked FDA effort to fast-track review of psychedelic treatmentStat News|2/4/2026
UNVERIFIEDSingle SourceSTAT+: Pfizer moves forward with its hopes for a monthly obesity drugStat News|2/3/2026
UNVERIFIEDSingle SourceSTAT+: FDA officials push for long-term monitoring of autoimmune patients receiving CAR-T therapyStat News|2/2/2026
UNVERIFIEDSingle SourceSTAT+: Why Bristol Myers Squibb believes a decades-old drug can treat Alzheimer’s Stat News|2/2/2026